Objective: To understand the prevalence and influencing factors of female thyroid diseases in Hefei city, and to provide reference and suggestions for effectively preventing and scientifically managing female thyroid diseases. Methods: A total of 4 724 women who received physical examination during January to October 2021 in a large tertiary hospital in Hefei city, Anhui Province were selected, their examination results were used to analyze the detection rate of thyroid disease and further to identify the risk factors through multifactorial logistic regression analysis. Results: The detection rate of female thyroid disease in Hefei city was 44.60%, and it significantly increased with the increase of age (P＜0.01). Furthermore, the results also showed that the age≥40 years, hypertension, overweight, hyperglycemia, hypercholesterolemia, and breast diseases were significantly associated with thyroid disease (P＜0.05), and thus were considered as risk factors for female thyroid disease (≥40 years). Conclusion: The detection rate of female thyroid disease in Hefeicity is high. For women aged≥40 years, overweight, suffering from breast disease and high blood pressure, blood glucose and total cholesterol, we should strengthen the awareness of thyroid disease prevention, actively carry out thyroid ultrasound examination, and strive to achieve early detection, early intervention and early treatment.
[1] Jing WZ, Liu J, Ma QY, et al. Fertility intentions to have a second or third child under China’s three-child policy: a national cross-sectional study[J]. Hum Reprod, 2022, 37(8): 1907-1918.
[2] Li YK, Huang YQ, He X, et al. The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the global burden of disease study[J]. Ther Adv Endocrinol Metab, 2022, 13: 20420188221090012.
[3] 高文君, 黄慧, 田凤美, 等. 育龄期甲状腺癌女性患者生育忧虑的潜在剖面分析[J]. 中华护理杂志, 2022, 57(22): 2738-2744.
[4] Li H, Wang Z, Liu JS, et al. Association between breast and thyroid lesions: a cross-sectional study based on ultrasonography screening in China[J]. Thyroid, 2020, 30(8): 1150-1158.
[5] Enewold L, Harlan LC, Stevens JL, et al. Thyroid cancer presentation and treatment in the United States[J]. Ann Surg Oncol, 2015, 22(6): 1789-1797.
[6] Meisinger C, Ittermann T, Wallaschofski H, et al. Geographic variations in the frequency of thyroid disorders and thyroid peroxidase antibodies in persons without former thyroid disease within Germany[J]. Eur J Endocrinol, 2012, 167(3): 363-371.
[7] 赖晓英, 欧阳平, 朱宏, 等. 甲状腺结节检出情况及影响因素:10年309576例体检人群分析[J]. 南方医科大学学报, 2020, 40(2): 268-273.
[8] Tran TV, Maringe C, Benitez Majano S, et al. Thyroid dysfunction and breast cancer risk among women in the UK Biobank cohort[J]. Cancer Med, 2021, 10(13): 4604-4614.
[9] 中国医疗保健国际交流促进会营养与代谢管理分会,中国营养学会临床营养分会, 中华医学会糖尿病学分会, 等. 中国超重/肥胖医学营养治疗指南(2021)[J]. 中国医学前沿杂志(电子版), 2021, 13(11): 1-55.
[10] 中国高血压防治指南修订委员会, 高血压联盟(中国), 中华医学会心血管病学分会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1): 24-56.
[11] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4): 311-398.
[12] 中国血脂管理指南修订联合专家委员会. 中国血脂管理指南(2023年)[J]. 中华心血管病杂志, 2023, 51(3): 221-255.
[13] 王健辉, 孙蕾, 冯晓伟, 等. 辽宁省成人甲状腺疾病流行状况及影响因素[J]. 中国公共卫生, 2022, 38(9): 1187-1192.
[14] 杨洋, 胥利. 重庆地区成年女性甲状腺结节检出情况及影响因素分析[J]. 现代预防医学, 2022, 49(11): 2054-2058,2064.
[15] Su Y, Zhang YL, Zhao M, et al. Association between thyroid nodules and volume and metabolic syndrome in an iodine-adequate area: a large community-based population study[J]. Metab Syndr Relat Disord, 2019, 17(4): 217-222.
[16] Zaki SM, Mohamed EA, Abdel Fattah S, et al. Age-associated functional morphology of thyroid and its impact on the expression of vimentin, cytokeratins and VEGF. The role of nigella in refinement[J]. Folia Histochem Cytobiol, 2018, 56(3): 159-171.
[17] Hu L, Li T, Yin XL, et al. An analysis of the correlation between thyroid nodules and metabolic syndrome[J]. Endocr Connect, 2020, 9(9): 933-938.
[18] 刘小莲, 张素芬, 郭玮珍, 等. 广东省医学放射工作人员甲状腺异常情况及影响因素[J]. 环境与职业医学, 2023, 40(3): 323-330.
[19] 曹毅, 李斌, 陈柯余, 等. 女性甲状腺结节与生活及月经生殖因素的相关性分析[J]. 中国慢性病预防与控制, 2020, 28(9): 692-695.
[20] 杨毅, 时立新, 张巧, 等. 贵阳市60岁及以上居民甲状腺结节与代谢综合征的相关性[J]. 中国老年学杂志, 2022, 42(22): 5438-5441.
[21] 王晓玮, 何殿, 张梦杰, 等. 适碘地区老年人群糖代谢紊乱与甲状腺结节患病率的相关性[J]. 重庆医科大学学报, 2022, 47(11): 1300-1304.
[22] Deng B, Yuan Y, Zhong M, et al. The relationship between metabolic parameters, age, and thyroid status: a cross-sectional study-based national survey of iodine nutrition, thyroid disease[J]. Risk Manag Healthc Policy, 2021, 14: 1723-1730.
[23] 翟玉倩, 刘智勇, 范丽珺. 碘及甲状腺功能与机体脂代谢关系的研究进展[J]. 中华地方病学杂志, 2022, 41(5): 420-424.
[24] 倪文婧, 徐书杭. 从流行病学角度看老年人甲状腺疾病的合理管理[J]. 重庆医科大学学报, 2022, 47(11): 1293-1296.
[25] Wang JY, Wang CY, Pei DE, et al. Association between thyroid function and metabolic syndrome in elderly subjects[J]. J Am Geriatr Soc, 2010, 58(8): 1613-1614.
[26] 刘雅思, 张先翠, 谢郁芳, 等. 不同BMI体检人群甲状腺结节检出情况和影响因素分析[J]. 齐齐哈尔医学院学报, 2023, 44(10): 972-978.
[27] 季明, 张楷, 邹子鸣, 等. 6096例健康体检教师人群甲状腺结节检出率及影响因素分析[J]. 南京医科大学学报(自然科学版), 2022, 42(9): 1287-1293.
[28] 佟丽喆,鲁丽. 不同血糖水平对甲状腺功能的影响研究[J]. 中国实用内科杂志, 2022, 42(2): 160-163.
[29] Hardefeldt PJ, Eslick GD, Edirimanne S. Benign thyroid disease is associated with breast cancer: a meta-analysis[J]. Breast Cancer Res Treat, 2012, 133(3): 1169-1177.
[30] 程卫. 乳腺癌患者经放射治疗后甲状腺功能变化情况及其临床意义分析[J]. 沈阳药科大学学报, 2021, 38(S2): 44-45.
[31] Halada S, Casado-Medrano V, Baran JA, et al. Hormonal crosstalk between thyroid and breast cancer[J]. Endocrinology, 2022, 163(7): bqac075.
[32] Baldini E, Lauro A, Tripodi D, et al. Thyroid diseases and breast cancer[J]. J Pers Med, 2022, 12(2): 156.
[33] 叶月, 甄洁玉, 闵行, 等. 绝经女性生殖因素与甲状腺结节的相关性研究[J]. 陆军军医大学学报, 2023, 45(6): 554-560.
[34] 吴丹, 漆仲文, 方文岩, 等. 乳腺癌与甲状腺疾病的相关性研究概述[J]. 现代肿瘤医学, 2021, 29(5): 896-900.
